Vimarsana
Biggest News Aggregation in the World

Page 2 - Udaykumar Murthy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Udaykumar Murthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Udaykumar Murthy Today - Breaking & Trending Today

Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US - Vimarsana News

Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in the US

/PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark...

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules® in Colombia - Vimarsana News

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules® in Colombia

/PRNewswire/ -- Glenmark Pharmaceuticals, an innovation–driven, global pharmaceutical company, today announced that its subsidiary Glenmark Pharmaceuticals...

Glenmark Pharmaceuticals Ltd: Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules in Colombia - Vimarsana News

Glenmark Pharmaceuticals Ltd: Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules in Colombia

- As per this agreement, AstraZeneca remains the holder of the registration for Pulmicort Respules and will manufacture the drug. Glenmark will commercialize the product in Colombia. -

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules® in Colombia - Vimarsana News

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules® in Colombia

/PRNewswire/ -- Glenmark Pharmaceuticals, an innovation–driven, global pharmaceutical company, today announced that its subsidiary Glenmark Pharmaceuticals...

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules® in Colombia - Vimarsana News

Glenmark inks agreement with AstraZeneca to commercialize its product Pulmicort Respules® in Colombia

/PRNewswire/ -- Glenmark Pharmaceuticals, an innovation–driven, global pharmaceutical company, today announced that its subsidiary Glenmark Pharmaceuticals...